Aenova, a contract developer and manufacturer for the pharmaceutical and healthcare industry, has expanded its Bad Aibling site. With a total investment of roughly 20 million euros in new production and packaging lines, the site offers a modern, high-volume infrastructure for the production of effervescent products and blister packaging.

The investment will go towards modernizing the machinery of the Bad Aibling site, the competence center for blister packaging / third-party packaging, and high volumes of effervescent products within the Aenova network. In February 2025, another new blister line was also put into operation.

“With these major investments, we can offer significantly increased production capacity on state-of-the-art, high-speed equipment and position ourselves as a preferred and strategic partner for our customers,” explained Thomas Lemke, Managing Director of the Aenova site in Bad Aibling.

The investment allows Aenova to offer faster blister lines and a capacity of around 220 million blisters per year. In the area of effervescent products, another new strip packaging line was commissioned at the beginning of the year, meaning that two strip lines and one tube line are now available for effervescent products. 

Over 420 million effervescent tablets per year can be produced and packaged in Bad Aibling. Further investments will follow, including a new explosion-proof fluid bed granulator for organic granulation. As a result, the site has a modern infrastructure that enables shorter delivery times and can grow with the customer.

Overall Aenova has 14 production sites and approximately 4,000 employees.